Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Germany OKs Northwest Bio brain cancer drug, shares soar
Yahoo/Reuters
Monday, March 10, 2014 - 5:06pm
tags:
Germany, glioblastoma multiforme, DCVax, Northwest Biotherapeutics
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Monday, March 10, 2014 - 5:05pm
tags:
M&A, InterMune, Sanofi, Esbriet, Boehringer Ingelheim, Novartis
GlaxoSmithKline Ups Its Stake in Indian Pharmaceutical Unit
Wall St Cheat Sheet
Monday, March 10, 2014 - 4:06pm
tags:
GSK, India
GW jumps ahead of CNN documentary on medical marijuana
The Fly on the Wall
Monday, March 10, 2014 - 4:05pm
tags:
GW Pharma, Medical Marijuana
Teva Copaxone Appeal Action Delayed by U.S. Supreme Court
Bloomberg
Monday, March 10, 2014 - 4:04pm
tags:
Copaxone, Teva Pharmaceuticals, MS, multiple sclerosis
Olympus abandons U.S. biotech biz
Mass Device
Monday, March 10, 2014 - 12:15pm
tags:
Olympus, devices, biotech, OP-1 bone growth putty
FirstWord Lists – Pharma's 50 biggest selling drugs: AbbVie's Humira joins the $10 billion club
First Word Pharma
Monday, March 10, 2014 - 11:56am
tags:
prescription data, Humira, AbbVie
A key Actos trial revs up in Vegas with demands for a $1B-plus judgment
Fierce Pharma
Monday, March 10, 2014 - 11:54am
tags:
Actos, Takeda, bladder cancer
J&J partners with a biotech start-up on a new approach to Alzheimer's
Fierce Biotech
Monday, March 10, 2014 - 10:19am
tags:
JNJ, Alzheimer's disease, Alector
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Monday, March 10, 2014 - 10:13am
tags:
Eli Lilly, Bristol-Myers Squibb, Merck, Pfizer, Yervoy, palbociclib, animal health, ramucirumab
Neuralstem Announces 2013 Financial Results
Yahoo
Monday, March 10, 2014 - 9:08am
tags:
Neuralstem
Alexion to book additional Soliris sales, raises outlook
Reuters
Monday, March 10, 2014 - 8:37am
tags:
Alexion, Soliris
The top 15 cities for biotech venture funding
Fierce Biotech
Monday, March 10, 2014 - 8:25am
tags:
biotech, funding, venture capital
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Monday, March 10, 2014 - 8:23am
tags:
InterMune, Aegerion, Emergent BioSolutions
Sequenom 2013 Operating Results Review
Seeking Alpha
Monday, March 10, 2014 - 8:22am
tags:
earnings, Sequenom
Reckitt Benckiser to buy K-Y from Johnson & Johnson
Yahoo/Reuters
Monday, March 10, 2014 - 8:21am
tags:
Reckitt Benckiser, JNJ, K-Y
Prices of new hepatitis C drugs are tough to swallow for insurers
LA Times, CA
Monday, March 10, 2014 - 8:19am
tags:
insurance, hepatitis C, Sovaldi, Gilead Sciences, Olysio, JNJ, Janssen
AstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient
Wall St Cheat Sheet
Monday, March 10, 2014 - 8:15am
tags:
Nexium, Ranbaxy, recalls, AstraZeneca
GlaxoSmithKline - Not Too Easy To Put Down
Seeking Alpha
Monday, March 10, 2014 - 8:14am
tags:
GSK
Drugs for rare diseases looming health hazard
Toronto Star, Canada
Sunday, March 9, 2014 - 1:44pm
tags:
orphan drugs, rare disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.